Leukoreduction and hydroxyurea in malignant pertussis: A case series
Author(s) -
Aldairi Nedaa,
Alali Hamza,
Kazzaz Yasser
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3264
Subject(s) - leukoreduction , medicine , intensive care medicine , whooping cough , pathology , blood transfusion , vaccination
We report five cases of malignant pertussis, a rare but life‐threatening illness. Current therapies include supportive care and leukoreduction. Notably, leukoreduction might be more effective when initiated prior to the development of organ failure and pulmonary hypertension.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom